Intabio, Inc. is a company developing analytical solutions to transform biotherapeutic development and manufacturing with products that provide early product quality characterization and profound efficiency gains across all stages of biopharmaceutical development and manufacturing. Intabio's first product, the Blaze system, is a microchip-based instrument system that will provide rapid detection and identification of subtle protein modifications - modifications that can undermine the stability and efficacy of biotherapeutic drugs such as monoclonal antibodies and recombinant proteins.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/30/18 | $9,500,000 | Series A |
Genoa Ventures Northpond Ventures  Vertical Venture Partners | undisclosed |
| 02/06/20 | $18,000,000 | Series B |
Genoa Ventures Northpond Ventures Vertical Venture Partners | undisclosed |
